Hamilton T1 Ventilator Recall Issued Over Oxygen Supply Problem

|

A recall has been issued for Hamilton-T1 ventilators, because of problems with oxygen consumption that could potentially be lethal for patients. 

The Bonaduz, Switzerland based Hamilton Medical AG initiated the ventilator recall on January 11. The company mailed a letter to its customer notifying them of problems with oxygen consumption which may result in severe health effects, including death.

This week, the FDA declared the action to be a Class I recall, which is the most severe type of recall and usually involves products which can potentially cause severe adverse health effects and may even result in death.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The small, portable ventilator is designed to provide intermittent breathing support to adults and pediatric patients in any medical care setting. However, while ventilating small pediatric patients with high airway resistance and low lung function, a problem with the T1 software caused high internal oxygen consumption.

The issue causes a miscalculation of the required oxygen a patient needs for an extended period of time, providing them with a limited oxygen supply.

Hamilton is in the process of developing a software version which will correct the oxygen consumption issue. Customers will be notified when the software update is complete and have been offered loaner units while their T1 units are repaired at the Reno based service department.

The recall letters sent to customers on January 11 also include an updated operators manual with an oxygen consumption formula page that provides information for calculating correct oxygen capacity.

The recall includes Hamilton-T1 Ventilators with Software Versions 1.1.2 and lower, part numbers 161005 and 161006, manufactured and distributed from February 2012 to December 2012. No deaths have been reported in connection with the T1 ventilator.

A national recall for another ventilator, the Life Pulse High-Frequency Ventilator Patient Circuits, was issued in December, after at least 12 reports of heater failure from wire insulation melting caused the device to spark and smoke, putting patients at risk of injury and death.

Customers with questions about the Hamilto-T1 Ventilator recall can call the company at (800) 426-6331. The FDA urges health care professionals and consumers to report adverse effects related to the ventilator recall to MedWatch, the FDA Safety Information and Adverse Event Reporting Program.

Written by: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.